TRE-VEGFA EF1a-rtTA3
(Plasmid
#195881)
-
PurposeLentiviral construct of doxycycline inducible VEGFA
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 195881 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepSpCTRE-CD4
-
Modifications to backboneReplace Cas9 with mVEGFA and removed CD4
-
Vector typeMammalian Expression, Lentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameVEGFA
-
SpeciesM. musculus (mouse)
-
Entrez GeneVegfa (a.k.a. L-VEGF, Vegf, Vpf)
- Promoter TRE3GS
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer cagggcgcctataaaagagt (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
TRE-VEGFA EF1a-rtTA3 was a gift from Elaine Fuchs (Addgene plasmid # 195881 ; http://n2t.net/addgene:195881 ; RRID:Addgene_195881) -
For your References section:
Ras drives malignancy through stem cell crosstalk with the microenvironment. Yuan S, Stewart KS, Yang Y, Abdusselamoglu MD, Parigi SM, Feinberg TY, Tumaneng K, Yang H, Levorse JM, Polak L, Ng D, Fuchs E. Nature. 2022 Nov 30. doi: 10.1038/s41586-022-05475-6. 10.1038/s41586-022-05475-6 PubMed 36450983